In a large target trial emulation of 174,678 people with type 1 diabetes, GLP-1 receptor agonist initiation was associated ...
MyChesCo on MSN
FDA fast-tracks higher-dose weight loss drug approval
WASHINGTON, D.C. — A new higher-dose version of a widely used weight loss drug has been approved on an accelerated timeline, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results